Skip to content
AVTX Avalo Therapeutics, Inc. Common Stock
$18.15 -3.56% -0.67
Notify me if price changes either direction
Interactive Brokers Logotype

Buy AVTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 954.1M
Enterprise value 875.6M
Trailing PE 2.3012233
Forward PE -6.586967
PEG Ratio -0.10653811574074
Enterprise to EBITDA -11.093
Enterprise to revenue 14839.899
Price to book MRQ 6.5668945
Price to sales TTM 16224.051

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 59000
EBITDA -78931000
Diluted EPS TTM -5.57
Total Cash (MRQ) 82.0M
Current ratio (MRQ) 7.658
Operating Cash Flow (TTM) -59692000

AVTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent AVTX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.